Monogenic muscular dystrophies (MDs), such as Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophy (LGMD), are characterized by chronic inflammation, progressive fibrosis, and impair
Published: April 16, 2025 Explor Immunol. 2025;5:1003192
Diet plays a complex role in the management of inflammatory bowel disease (IBD), significantly influencing the microbiome and metabolome. Three key metabolites implicated in IBD are short chain fatt
Published: April 08, 2025 Explor Immunol. 2025;5:1003191
Neoantigen vaccines are a promising strategy in cancer immunotherapy that leverage tumor-specific mutations to elicit targeted immune responses. Although they have considerable potential, developmen
Published: April 08, 2025 Explor Immunol. 2025;5:1003190
Aim:
To assess circulating levels of tumor necrosis factor-alpha (TNF-α) and transforming growth factor-beta (TGF-β) in mid-gestation pregnant women from South India, with (RPL) and without his
Published: April 08, 2025 Explor Immunol. 2025;5:1003189
Cutaneous reactions present a diagnostic challenge, mainly when multiple factors, such as infections, medications, and environmental triggers, contribute to the clinical picture. Erythema multiforme
Published: March 20, 2025 Explor Immunol. 2025;5:1003188
Immune response, inflammation, and lipid metabolism have important effects on cancer development and progression. Several proteins in tumoral cells and/or tumor microenvironment are involved in any
Published: March 20, 2025 Explor Immunol. 2025;5:1003187
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; βCoV), the causative agent of coronavirus disease 2019 (COVID-19), causes severe lower respiratory tract infections and acute
Published: December 31, 2021 Explor Immunol. 2021;1:341–355
Repeated inoculation with messenger RNA (mRNA) vaccines elicits immunoglobulin G4 (IgG4) antibody production. Such an increase in the concentration of specific and non-specific IgG4 antibodies allow
Published: April 25, 2024 Explor Immunol. 2024;4:267–284
Rheumatoid arthritis (RA) is a complex autoimmune disorder characterized by a spectrum of hypersensitivity reactions, encompassing Type II, Type III, and Type IV responses. Firstly, RA is marked by
Published: June 20, 2024 Explor Immunol. 2024;4:358–375
There have been significant developments in the design of nanostructured scaffolds for eliciting robust immune responses named vaccine. The technique is to produce strong immune responses is to mani
Published: October 31, 2021 Explor Immunol. 2021;1:243–257
Atopic dermatitis (AD) is characterized by skin barrier disruption, type 2 immune dysregulation, chronic pruritus, and abnormal colonization by Staphylococcus aureus (S. aureus). Tapinarof, an aryl
Published: April 30, 2021 Explor Immunol. 2021;1:4–15
Humans are afflicted by a wide spectrum of autoimmune disorders, ranging from those affecting just one or a few organs to those associated with more systemic effects. In most instances, the etiology
Published: June 07, 2022 Explor Immunol. 2022;2:351–362
Repeated inoculation with messenger RNA (mRNA) vaccines elicits immunoglobulin G4 (IgG4) antibody production. Such an increase in the concentration of specific and non-specific IgG4 antibodies allow
Published: April 25, 2024 Explor Immunol. 2024;4:267–284
Chemokines are homeostatic or inflammatory small proteins regulating immune cell migration and are structurally characterized by cysteine disulfide bridges. Around 50 human chemokines binding almost
Published: August 31, 2022 Explor Immunol. 2022;2:637–647
Immunity is continuously evolving by evolutionary mechanisms shaped by pathogenic stimuli of different kinds. Man-made nanomaterials (NMs) have been developed in the last decades and represent a nov
Published: April 30, 2021 Explor Immunol. 2021;1:48–60
Atopic dermatitis (AD) is characterized by skin barrier disruption, type 2 immune dysregulation, chronic pruritus, and abnormal colonization by Staphylococcus aureus (S. aureus). Tapinarof, an aryl
Published: April 30, 2021 Explor Immunol. 2021;1:4–15
Cutaneous homeostasis is maintained by dynamic cellular communications between different cell types in the skin through interactions with various mediators, including cytokines, chemokines and antim
Published: December 31, 2021 Explor Immunol. 2021;1:418–431
Interleukin (IL)-22 is produced from immune cells such as T helper (Th)22 cells, Th17/22 cells, and group 3 innate lymphoid cells. IL-22 signals via the IL-22 receptor 1 (IL-22R1) and the IL-10 rece
Published: April 30, 2021 Explor Immunol. 2021;1:37–47
Cancer immunotherapy, especially T-cell driven targeting, has significantly evolved and improved over the past decade, paving the way to treat previously refractory cancers. Hematologic malignancies
Published: June 07, 2022 Explor Immunol. 2022;2:334–350
Cutaneous homeostasis is maintained by dynamic cellular communications between different cell types in the skin through interactions with various mediators, including cytokines, chemokines and antim
Published: December 31, 2021 Explor Immunol. 2021;1:418–431
Avidity of immunoglobulin G (IgG) is defined as its binding strength to its target antigen. As a consequence of affinity maturation of the IgG response, avidity is maturing as well. Therefore, acute
Published: March 16, 2022 Explor Immunol. 2022;2:133–156
Mesenchymal stromal cells (MSCs) are a mesodermal stem cell population, with known self-renewal and multilineage differentiation properties. In the last century, MSCs have been widely used in regene
Published: June 30, 2021 Explor Immunol. 2021;1:112–139
There have been significant developments in the design of nanostructured scaffolds for eliciting robust immune responses named vaccine. The technique is to produce strong immune responses is to mani
Published: October 31, 2021 Explor Immunol. 2021;1:243–257
Immunity is continuously evolving by evolutionary mechanisms shaped by pathogenic stimuli of different kinds. Man-made nanomaterials (NMs) have been developed in the last decades and represent a nov
Published: April 30, 2021 Explor Immunol. 2021;1:48–60